161 related articles for article (PubMed ID: 10472534)
21. The diagnosis and biochemical investigation of a patient with a short chain fatty acid oxidation defect.
Bennett MJ; Gray RG; Isherwood DM; Murphy N; Pollitt RJ
J Inherit Metab Dis; 1985; 8 Suppl 2():135-6. PubMed ID: 3930866
[No Abstract] [Full Text] [Related]
22. The inborn errors of mitochondrial fatty acid oxidation.
Vianey-Liaud C; Divry P; Gregersen N; Mathieu M
J Inherit Metab Dis; 1987; 10 Suppl 1():159-200. PubMed ID: 3119938
[TBL] [Abstract][Full Text] [Related]
23. Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
Sim KG; Hammond J; Wilcken B
Clin Chim Acta; 2002 Sep; 323(1-2):37-58. PubMed ID: 12135806
[TBL] [Abstract][Full Text] [Related]
24. Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts an adrenal cortex.
Singh I; Moser HW; Moser AB; Kishimoto Y
Biochem Biophys Res Commun; 1981 Oct; 102(4):1223-9. PubMed ID: 6797420
[No Abstract] [Full Text] [Related]
25. A novel method for determining peroxisomal fatty acid β-oxidation.
Morita M; Matsumoto S; Okazaki A; Tomita K; Watanabe S; Kawaguchi K; Minato D; Matsuya Y; Shimozawa N; Imanaka T
J Inherit Metab Dis; 2016 Sep; 39(5):725-731. PubMed ID: 27324171
[TBL] [Abstract][Full Text] [Related]
26. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation.
Schaefer J; Pourfarzam M; Bartlett K; Jackson S; Turnbull DM
Pediatr Res; 1995 Mar; 37(3):354-60. PubMed ID: 7784145
[TBL] [Abstract][Full Text] [Related]
27. Defects of mitochondrial beta-oxidation: a growing group of disorders.
Vockley J; Whiteman DA
Neuromuscul Disord; 2002 Mar; 12(3):235-46. PubMed ID: 11801395
[TBL] [Abstract][Full Text] [Related]
28. The changing face of disorders of fatty acid oxidation.
Vockley J
Mayo Clin Proc; 1994 Mar; 69(3):249-57. PubMed ID: 8133663
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
30. Prenatal diagnosis of a defect in medium-chain fatty acid oxidation.
Pollitt RJ; Manning NJ; Olpin SE; Young ID
J Inherit Metab Dis; 1994; 17(3):279-82. PubMed ID: 7807933
[No Abstract] [Full Text] [Related]
31. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects.
Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R
J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847
[No Abstract] [Full Text] [Related]
32. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
[TBL] [Abstract][Full Text] [Related]
33. Fatty acid oxidation in fibroblasts from patients with defects in beta-oxidation and in the respiratory chain.
Venizelos N; von Döbeln U; Hagenfeldt L
J Inherit Metab Dis; 1998 Jun; 21(4):409-15. PubMed ID: 9700598
[TBL] [Abstract][Full Text] [Related]
34. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts.
Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C
J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924
[TBL] [Abstract][Full Text] [Related]
35. Fatty acid oxidation disorders: a new class of metabolic diseases.
Hale DE; Bennett MJ
J Pediatr; 1992 Jul; 121(1):1-11. PubMed ID: 1625065
[No Abstract] [Full Text] [Related]
36. Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.
Vianey-Saban C; Divry P; Brivet M; Nada M; Zabot MT; Mathieu M; Roe C
Clin Chim Acta; 1998 Jan; 269(1):43-62. PubMed ID: 9498103
[TBL] [Abstract][Full Text] [Related]
37. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of mitochondrial fatty acid oxidation defects.
Duran M; Bruinvis L; Ketting D; Dorland L
Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
[TBL] [Abstract][Full Text] [Related]
39. Identification of propionate as a degradation product of phytanic acid oxidation in rat and human tissues.
Hutton D; Steinberg D
J Biol Chem; 1973 Oct; 248(19):6871-5. PubMed ID: 4745448
[No Abstract] [Full Text] [Related]
40. [Clinical protocols concerned with disorders of fatty acid beta oxidation].
Kania M
Przegl Lek; 1994; 51(1):25-8. PubMed ID: 8208992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
